4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cantourage Group SE (HIGH) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Berlin, Germany. Its market capitalization is roughly €69 million. In the fiscal year ended 2023-12-31, HIGH reported €24M in revenue and (€4M) in net income.
Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners.
Interactive charts & full statements →
| Income statement | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Revenue | €24M | €1M | €5M |
| Gross Profit | €7M | — | €2M |
| Operating Income (EBIT) | (€4M) | €0M | (€1M) |
| Net Income | (€4M) | €0M | (€1M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Assets | €44M | €45M | €5M |
| Total Liabilities | €4M | €1M | €1M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HIGH viewer.
About TickerBase · Data methodology & sources · Privacy · Terms